The people behind the playbook

Operators.
Not theorists.

KA Clinical was founded by two people who have built drug-development programs — and the organizations behind them — from every side of the table.

Every stage

preclinical » clinical » launch

20+

years average experience

Four perspectives

research · site · CRO · sponsor

Six continents

trials run and managed(sorry, Antarctica)

What we believe

Good process should enable—not disable.

Rules should protect patients and data—not bury teams in paperwork. Good process makes risk visible, focuses attention, and prompts early action. If it gets in the way of the work, it isn’t good process.

Say it like a person.

We turn dense regulations into plain language, clear decisions, and practical next steps. If you need a glossary, we haven’t done our job.

Make learning stick.

Training should be engaging, memorable, and useful when it matters—not just another certificate.

Catch it. Don’t just log it.

Checklists prove you looked. Good tools surface issues early, so teams can act before risk becomes rework.

Automate the drudgery. Keep judgment human.

AI should speed the work and strengthen the record—not hide decisions. People make the judgment calls; controls match the risk.

Our Cofounders

Complementary strengths. One shared standard.

Christine Dobek, co-founder of KA Clinical.

Sound principles

Christine Dobek

Co-Founder · MSc, BSc

Christine brings 17 years across research sites, CROs, and sponsors. She builds clinical operations, leads global programs, and gets high-pressure studies back on track.

Track record

Zero critical findings in a CRO regulatory inspection.

✓ Delivered $4M+ in annual cost efficiencies.

✓ Rescued a 2,500-patient, 100+ site trial, and enrolled a rare-disease study at 2.5× the industry rate.

✓ Led company-wide adoption of ICH E6(R2) and E6(R3).

Christine on LinkedIn →
Vik Peck, co-founder of KA Clinical.

Stronger execution

Vik Peck

Co-Founder · MBA · B.Journ/BSc · PMP · RAC

Vik brings 25+ years in biotech and global pharma, most recently as SVP Operations. She builds the teams, functions, and governance that move programs from early development through global launch.

Track record

✓ Built operations at a fledgling CRO and two biotechs from the ground up.

✓ Managed multi-program portfolios and annual development budgets up to USD $50M.

✓ Led development, regulation and launch across 15 countries with Asia-Pacific partners.

✓ Helped lead Canada's first TSX-only biotech IPO in 18 years (EPRX).

Vik on LinkedIn →
A team of miniature figures lifting an oversized capsule together.

Our Associates

Our growing team.

We work with an ever-growing bench of Associates — senior specialists averaging 15+ years in the field. The goal: cover the entire spectrum of pharma skills, so whatever a program needs, the right expert is one email away.

Engage our services Become an Associate

Start where it helps.

Free resources to get going, or the toolkits when you're ready to move.

Download the free resources Browse the toolkits